Patents by Inventor Neil A. Solomon

Neil A. Solomon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240077469
    Abstract: Provided herein are methods of employing pharmacodynamics regimens to maximize effectiveness of voclosporin in treatment of proteinuric kidney diseases while minimizing undesirable side effects, such as but not limited to calcineurin inhibitor nephrotoxicity. Also provided are methods of assessments of renal functions and/or conditions, and corresponding protocols to modify, stop, restore and/or re-initiate voclosporin dosing and administrations to maximize effectiveness of voclosporin in treatment of proteinuric kidney diseases while minimizing undesirable side effects.
    Type: Application
    Filed: January 14, 2022
    Publication date: March 7, 2024
    Applicant: Aurinia Pharmaceuticals Inc.
    Inventors: Michael MARTIN, Robert B. HUIZINGA, Neil SOLOMONS
  • Publication number: 20230381271
    Abstract: Provided herein are methods of employing pharmacodynamics regimens to maximize effectiveness of voclosporin in treatment of proteinuric kidney diseases while minimizing undesirable side effects, such as but not limited to calcineurin inhibitor nephrotoxicity. Also provided are methods of assessments of renal functions and/or conditions, and corresponding protocols to modify, stop, restore and/or re-initiate voclosporin dosing and administrations to maximize effectiveness of voclosporin in treatment of proteinuric kidney diseases while minimizing undesirable side effects.
    Type: Application
    Filed: July 28, 2023
    Publication date: November 30, 2023
    Applicant: Aurinia Pharmaceuticals Inc.
    Inventors: Michael Martin, Robert B. Huizinga, Neil Solomons
  • Publication number: 20230183293
    Abstract: Provided herein are methods of using voclosporin for treating or preventing coronavirus infection, particularly in subjects that require immunosuppression.
    Type: Application
    Filed: May 8, 2021
    Publication date: June 15, 2023
    Applicant: Aurinia Pharmaceuticals Inc.
    Inventors: Y.K. Onno TENG, Robert B. HUIZINGA, Neil SOLOMONS, Jennifer CROSS
  • Patent number: 11622991
    Abstract: By employing a pharmacodynamic dosing regimen, the effectiveness of a protocol for treatment of a proteinuric kidney disease with voclosporin can be maximized while minimizing undesirable side effects.
    Type: Grant
    Filed: April 4, 2022
    Date of Patent: April 11, 2023
    Assignee: Aurinia Pharmaceuticals Inc.
    Inventors: Neil Solomons, Robert B. Huizinga
  • Publication number: 20220226428
    Abstract: By employing a pharmacodynamic dosing regimen, the effectiveness of a protocol for treatment of a proteinuric kidney disease with voclosporin can be maximized while minimizing undesirable side effects.
    Type: Application
    Filed: April 4, 2022
    Publication date: July 21, 2022
    Applicant: Aurinia Pharmaceuticals Inc.
    Inventors: Neil SOLOMONS, Robert B. HUIZINGA
  • Publication number: 20190224275
    Abstract: By employing a pharmacodynamic dosing regimen, the effectiveness of a protocol for treatment of a proteinuric kidney disease with voclosporin can be maximized while minimizing undesirable side effects.
    Type: Application
    Filed: April 3, 2019
    Publication date: July 25, 2019
    Applicant: AURINIA PHARMACEUTICALS INC.
    Inventors: Neil SOLOMONS, Robert B. HUIZINGA
  • Patent number: 10286036
    Abstract: By employing a pharmacodynamic dosing regimen, the effectiveness of a protocol for treatment of lupus nephritis with voclosporin can be maximized while minimizing undesirable side effects.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: May 14, 2019
    Assignee: AURINIA PHARMACEUTICALS INC.
    Inventors: Neil Solomons, Robert B. Huizinga
  • Publication number: 20180325995
    Abstract: By employing a pharmacodynamic dosing regimen, the effectiveness of a protocol for treatment of lupus nephritis with voclosporin can be maximized while minimizing undesirable side effects.
    Type: Application
    Filed: December 7, 2017
    Publication date: November 15, 2018
    Applicant: AURINIA PHARMACEUTICALS INC.
    Inventors: Neil SOLOMONS, Robert B. HUIZINGA
  • Publication number: 20130058913
    Abstract: A particulate composition comprising a plurality of particles comprising lactase and a protective material are provided. The particles have a size that is not perceptible or is minimally perceptible on the human tongue. The particulate composition can be made by a method that comprises the steps of providing a lactase, providing a protective material, and forming a particulate composition comprising a plurality of particles comprising the lactase and the protective material in a size that is not perceptible or barely perceptible on the human tongue. The particulate composition can be used by applying the lactase composition to a food article or by using the lactase composition in the course of consuming the food article.
    Type: Application
    Filed: October 30, 2012
    Publication date: March 7, 2013
    Inventor: Neil A. Solomon
  • Patent number: 8298596
    Abstract: A particulate composition comprising a plurality of particles comprising lactase and a protective material are provided. The particles have a size that is not perceptible or is minimally perceptible on the human tongue. The particulate composition can be made by a method that comprises the steps of providing a lactase, providing a protective material, and forming a particulate composition comprising a plurality of particles comprising the lactase and the protective material in a size that is not perceptible or barely perceptible on the human tongue. The particulate composition can be used by applying the lactase composition to a food article or by using the lactase composition in the course of consuming the food article.
    Type: Grant
    Filed: February 14, 2008
    Date of Patent: October 30, 2012
    Inventor: Neil A. Solomon
  • Publication number: 20080193598
    Abstract: A particulate composition comprising a plurality of particles comprising lactase and a protective material are provided. The particles have a size that is not perceptible or is minimally perceptible on the human tongue. The particulate composition can be made by a method that comprises the steps of providing a lactase, providing a protective material, and forming a particulate composition comprising a plurality of particles comprising the lactase and the protective material in a size that is not perceptible or barely perceptible on the human tongue. The particulate composition can be used by applying the lactase composition to a food article or by using the lactase composition in the course of consuming the food article.
    Type: Application
    Filed: February 14, 2008
    Publication date: August 14, 2008
    Inventor: NEIL A. SOLOMON
  • Patent number: 5334390
    Abstract: Method for alleviating symptoms of nicotine withdrawal employing calcium carbonate.
    Type: Grant
    Filed: November 5, 1992
    Date of Patent: August 2, 1994
    Inventors: Neil Solomon, Theodore C. Solomon, Allen J. Freed
  • Patent number: 4833128
    Abstract: A dietary supplement formulated to suppress appetite comprising L-phenylalanine in combination with restricted quantities of protein, carbohydrate, fat and dietary fiber.
    Type: Grant
    Filed: October 17, 1986
    Date of Patent: May 23, 1989
    Inventors: Neil Solomon, Theodore C. Solomon